Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00240188
Other study ID # CLIN-011-03S
Secondary ID
Status Completed
Phase N/A
First received August 30, 2005
Last updated September 15, 2010
Start date February 2004
Est. completion date December 2006

Study information

Verified date September 2010
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this research is to compare open ventral incisional hernia repair to the laparoscopic repair with respect to complications, recurrence, pain, return to normal activities of daily living, and return to work.


Description:

The appearance of ventral incisional hernia (VIH) following an open abdominal operation is an important postoperative problem. While advances in anesthesia techniques, better methods to prevent surgical infections, and improved treatment of infection, and the use of new suture materials have reduced the incidence of incisional hernias, incisional hernias still occurs in 0.5-11% of all open abdominal surgical procedures performed.

Overview of study design: We are conducting a 4 center randomized clinical trial to compare the outcomes of two methods of surgical management of ventral incisional hernia. Patients presenting to a physician with a ventral incisional hernia will be considered for the trial. The study is designed to compare the rate of complications, pain, time to return to normal activities, Health related quality of life (HRQoL) and patient satisfaction between laparoscopic and open mesh repair for ventral incisional hernia. The rate of recurrence of the hernia at 1-2 years will be evaluated as a secondary outcome. Four VA medical centers with the capability of enrolling 40-50 patients a year have been selected based on volume, experience with open and laparoscopic ventral herniorrhaphy and experience in the conduct of clinical trials. Patients are recruited by physicians at each site and referred to the site coordinator who screens them for eligibility. The trial is randomized but not blinded. The randomization scheme takes into consideration that random allocation of patients to each study group is made within each center. In addition to the participating center, the other baseline variables that serve as stratification factors are first time or recurrent ventral incisional hernia and patient with a body mass index greater or less than 35arm.

Timeline: The trial consists of 3 phases: Implementation, Patient intake and follow-up, closeout and final analysis. 1-Implementation (2 months): The implementation which will include funding, recruitment of the nurse coordinators and review of the study protocol and techniques of operation was 2 months in duration. 2-Patient intake and follow up (32 months): All study patients are recruited during that period of time. Follow-up will occur simultaneously and will end at close out. The range of follow-up is expected to range from 8 weeks to 34 months. 4-Final analysis and closeout: The participating centers will be given 2 months of funding to close out the data collection. During this period, all final follow-up visits and data collection will be completed. Final analysis will run concurrently with closeout.


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date December 2006
Est. primary completion date December 2006
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

Patients will be eligible for enrollment into the study if they meet the following criteria: -Are 18 years of age or older -Have a diagnosis of ventral primary incisional hernia 9-225 cm2 in size. -Give informed consent for randomization - Have a negative pregnancy test. (Women)

Exclusion Criteria:

Patients will be excluded for the following reasons: -Hernia cannot be detected on physical examination - Primary ventral or umbilical hernia - Small hernia defined as less than 9 cm2 - Giant hernia defined as greater than 225 cm2 in size - ASA class 4 or 5, or contraindications to general anesthesia - Severe co morbid conditions likely to limit survival to less than 3 years - History of malignancy within the past 5 years except for non-melanoma skin cancer - Cirrhosis with or without ascites - Presence of bowel obstruction( partial or intermittent), strangulation, peritonitis, or perforation. - Presence of local or systemic infection - Participation in another clinical trial - Emergency operation - Prisoner

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Open mesh repair of ventral incisional hernia
For the open procedure, the technique, as described by Chevrel and others was adopted.
Laparoscopic mesh repair of ventral incisional hernia
For the laparoscopic repair, the method of Gagner was adopted

Locations

Country Name City State
United States VA Boston Healthcare System, Boston Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

References & Publications (5)

Itani KM, Hur K, Kim LT, Anthony T, Berger DH, Reda D, Neumayer L; Veterans Affairs Ventral Incisional Hernia Investigators. Comparison of laparoscopic and open repair with mesh for the treatment of ventral incisional hernia: a randomized trial. Arch Surg — View Citation

Itani KM, Neumayer L, Reda D, Kim L, Anthony T. Repair of ventral incisional hernia: the design of a randomized trial to compare open and laparoscopic surgical techniques. Am J Surg. 2004 Dec;188(6A Suppl):22S-29S. — View Citation

Kaafarani HM, Hur K, Campasano M, Reda DJ, Itani KM. Classification and valuation of postoperative complications in a randomized trial of open versus laparoscopic ventral herniorrhaphy. Hernia. 2010 Jun;14(3):231-5. doi: 10.1007/s10029-009-0593-z. Epub 20 — View Citation

Kaafarani HM, Hur K, Hirter A, Kim LT, Thomas A, Berger DH, Reda D, Itani KM. Seroma in ventral incisional herniorrhaphy: incidence, predictors and outcome. Am J Surg. 2009 Nov;198(5):639-44. doi: 10.1016/j.amjsurg.2009.07.019. — View Citation

Kaafarani HM, Kaufman D, Reda D, Itani KM. Predictors of surgical site infection in laparoscopic and open ventral incisional herniorrhaphy. J Surg Res. 2010 Oct;163(2):229-34. doi: 10.1016/j.jss.2010.03.019. Epub 2010 Apr 1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Overall complication rates at eight weeks and the odds of complications, adjusted for study site, body mass index, and hernia type Eight (8) weeks post-operatively No
Secondary Compare pain, return to normal activities of daily living, and return to work. Health related quality of life, and recurrence. One (1) and two (2) years post-operatively No
See also
  Status Clinical Trial Phase
Recruiting NCT06051578 - Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
Recruiting NCT04098380 - Small Versus Large Bite Closure of Emergency Midline Laparotomy N/A
Completed NCT02616718 - Incisional Hernia Progression Over Time N/A
Completed NCT06034652 - T-GENVIH-003 LTFU (Long Term Follow Up) Study
Completed NCT04222517 - The Use of Local Hemostatic in Patients With Large Incisional Hernias N/A
Completed NCT00749268 - AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair Phase 4
Not yet recruiting NCT05467124 - Enhanced Recovery After Abdominal Wall Reconstruction
Completed NCT00472537 - ProLOVE - Prospective Randomized Study of Midline Incisional Hernia Treatment N/A
Active, not recruiting NCT02365194 - Modifying Risk in Ventral Hernia Patients N/A
Recruiting NCT04718168 - GORE® ENFORM Biomaterial Product Study N/A
Completed NCT02594241 - PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial N/A
Active, not recruiting NCT02363790 - Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial N/A
Completed NCT02398565 - Pregnancy Subsequent to Ventral Hernia Repair N/A
Terminated NCT02041494 - Complex Ventral Hernia Repair Using Biologic or Synthetic Mesh N/A
Completed NCT00532870 - Laparoscopic Intraperitoneal Mesh Repair of Ventral Hernia: Comparison to Conventional Mesh Repair N/A
Completed NCT05320055 - Pain and Readmission After Lap IPOM vs. Robotic Ventral Hernia Repair
Completed NCT04229940 - Peritoneal in Laparoscopic Ventral Hernia Repair 2 Phase 2
Completed NCT05446675 - Endoscopic eTEP Versus Open Rives-Stoppa
Completed NCT05912868 - Endoscopic Mini/Less Open Sublay(EMILOS) Repair
Not yet recruiting NCT06449378 - Transorbâ„¢ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia N/A